Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of RNA-Based Therapeutics and Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNA-Based Therapeutics and Vaccinesmarket, defines the market attractiveness level of RNA-Based Therapeutics and Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNA-Based Therapeutics and Vaccines industry, describes the types of RNA-Based Therapeutics and Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA-Based Therapeutics and Vaccines market and the development prospects and opportunities of RNA-Based Therapeutics and Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA-Based Therapeutics and Vaccines market in Chapter 13.
By Player:
Alnylam Pharmaceuticals
MiRagen Therapeutics
BioNTech
CureVac
Regulus Therapeutics
Roche
Moderna Therapeutics
Marina Biotech
Arbutus Biopharma
Sylentis
Quark Pharmaceuticals
Arrowhead Pharmaceuticals
Dicerna Pharmaceuticals
By Type:
RNA-Based Therapeutics
RNA-Based Vaccines
By End-User:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNA-Based Therapeutics and Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNA-Based Therapeutics and Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNA-Based Therapeutics and Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNA-Based Therapeutics and Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNA-Based Therapeutics and Vaccines Market Analysis and Outlook to 2022
-
7.1 Global RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.2 United States RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.3 Europe RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.4 China RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.5 Japan RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.6 India RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
7.7 South Korea RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
8 Region and Country-wise RNA-Based Therapeutics and Vaccines Market Analysis and Outlook to 2028
-
8.1 Global RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.2 United States RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.4 China RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.6 India RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
9 Global RNA-Based Therapeutics and Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global RNA-Based Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immunology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Genetic Diseases Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global RNA-Based Therapeutics and Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global RNA-Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global RNA-Based Therapeutics and Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNA-Based Therapeutics and Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNA-Based Therapeutics and Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNA-Based Therapeutics and Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNA-Based Therapeutics and Vaccines Market Competitive Analysis
-
14.1 Alnylam Pharmaceuticals
-
14.1.1 Alnylam Pharmaceuticals Company Details
-
14.1.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
14.2 MiRagen Therapeutics
-
14.2.1 MiRagen Therapeutics Company Details
-
14.2.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
14.3 BioNTech
-
14.3.1 BioNTech Company Details
-
14.3.2 BioNTech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 BioNTech RNA-Based Therapeutics and Vaccines Product and Service
-
14.4 CureVac
-
14.4.1 CureVac Company Details
-
14.4.2 CureVac RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CureVac RNA-Based Therapeutics and Vaccines Product and Service
-
14.5 Regulus Therapeutics
-
14.5.1 Regulus Therapeutics Company Details
-
14.5.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche RNA-Based Therapeutics and Vaccines Product and Service
-
14.7 Moderna Therapeutics
-
14.7.1 Moderna Therapeutics Company Details
-
14.7.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
14.8 Marina Biotech
-
14.8.1 Marina Biotech Company Details
-
14.8.2 Marina Biotech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Product and Service
-
14.9 Arbutus Biopharma
-
14.9.1 Arbutus Biopharma Company Details
-
14.9.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product and Service
-
14.10 Sylentis
-
14.10.1 Sylentis Company Details
-
14.10.2 Sylentis RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sylentis RNA-Based Therapeutics and Vaccines Product and Service
-
14.11 Quark Pharmaceuticals
-
14.11.1 Quark Pharmaceuticals Company Details
-
14.11.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
14.12 Arrowhead Pharmaceuticals
-
14.12.1 Arrowhead Pharmaceuticals Company Details
-
14.12.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
14.13 Dicerna Pharmaceuticals
-
14.13.1 Dicerna Pharmaceuticals Company Details
-
14.13.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNA-Based Therapeutics and Vaccines
-
Figure RNA-Based Therapeutics and Vaccines Picture
-
Table Global RNA-Based Therapeutics and Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA-Based Therapeutics and Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure United States RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
Table MiRagen Therapeutics (Foundation Year, Company Profile and etc.)
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
Table BioNTech (Foundation Year, Company Profile and etc.)
-
Table BioNTech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech RNA-Based Therapeutics and Vaccines Product and Service
-
Table CureVac (Foundation Year, Company Profile and etc.)
-
Table CureVac RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac RNA-Based Therapeutics and Vaccines Product and Service
-
Table Regulus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA-Based Therapeutics and Vaccines Product and Service
-
Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product and Service
-
Table Marina Biotech (Foundation Year, Company Profile and etc.)
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Product and Service
-
Table Arbutus Biopharma (Foundation Year, Company Profile and etc.)
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product and Service
-
Table Sylentis (Foundation Year, Company Profile and etc.)
-
Table Sylentis RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sylentis RNA-Based Therapeutics and Vaccines Product and Service
-
Table Quark Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
Table Arrowhead Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
Table Dicerna Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product and Service
-
